secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q/C TECHNOLOGIES, INC. (QCLS)
CIK:        0001321834
Form:       8-K
Filed at:   2023-10-13T23:59:59+00:00
Accession:  0001493152-23-037209
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

MyMD Pharmaceuticals receives Nasdaq deficiency notice for bid price below $1.00
--------------------------------------------------------------------------------

- Received Nasdaq letter on Oct 11, 2023, for failing to maintain $1.00 closing bid price for 30 consecutive business days.
- Has until April 8, 2024 (180-day compliance period) to regain compliance by achieving $1.00 closing bid for 10 consecutive days.
- If not compliant by April 8, may receive additional 180-day cure period if meeting other listing standards.
- No immediate delisting; stock continues trading on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321834/000149315223037209/0001493152-23-037209-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321834/000149315223037209/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-037209

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer